Hybrid Event | Lunch and Learn with CASTL
Join D2R and CASTL聽for this hybrid Lunch and Learn about biomanufacturing and RNA therapeutics
In this presentation, D2R and CASTL will connect the world of research with industrial applications! This Lunch and Learn will provide a practical way introduce participants to how mRNA-LNP based biotherapeutics are manufactured, and showcase opportunities and career pathways in the biomanufacturing sector.聽
Event | Introduction to Applying Equity, Diversity and Inclusion in Genomic-Based RNA Therapeutics Research
Join D2R for a learning opportunity to gain foundational knowledge and practical tools to embed Equity, Diversity and Inclusion (EDI) into your genomic-based RNA therapeutics research.聽Through engaging discussions and activities, participants will explore key EDI definitions, examine both opportunities and challenges in the field, and learn best practices for inclusive research design.
Event | Breast Cancer & RNA Therapeutics: Exploring inclusive research and career opportunities
Join D2R聽and the聽Rosalind and Morris Goodman Cancer Institute (GCI)聽for an event in honour of Breast Cancer Awareness Month and Women's History Month, in collaboration with Fondation du cancer du sein du Qu茅bec and the association Audace au f茅minin
Event | Symposium on Advances in Viral Diseases
The 涩里番 Research Centre for Complex Traits, the Wainberg Centre for Viral Diseases and the 涩里番 Infectious Diseases and Immunity in Global Health Program are joined to host a聽Symposium on Advances in Viral Diseases: From Mechanisms to Therapies.
Event | RNA-Seq Bootcamp
From October 20鈥�24, 2025, the聽Computational and Data Systems Initiative,聽in partnership with聽Quantitative Life Sciences-涩里番 initiative in Computational Medicine聽and the聽D2R-HeDS Platform (Health Data Science), will host an聽RNA-seq Bootcamp.
Inaugural Moderna-RNA Canada ARN awarded to D2R-funded researcher Professor Maria Vera Ugalde
Montreal, September 24, 2025 鈥� Moderna, in partnership with RNA Canada, has awarded three prizes this year to RNA researchers in Canada for their outstanding contribution to the field. D2R is proud to announce that Professor Maria Vera Ugalde has received the Discovery of the Year Award for her seminal 2024 publication in Nature Communications (Alecki et al.,).
Event | AReNA "From Mission to Action"
AReNA, Qu茅bec鈥檚 RNA Hub, is inviting everyone involved in the field of RNA in Qu茅bec鈥攔esearchers, innovators, institutions, partners, anyone curious about the field, as well as experts鈥攖o attend the event "From Mission to Action" on October 16, 2025 at the BAnQ in Montr茅al.聽
Cancer Translational Research Horizons 2025 | Extended Abstract Deadline
The 涩里番 Centre for Translational Research is organizing the聽Cancer Translational Research Horizons 2025, that will take place on December 3鈥�4, 2025 at the evo Hotel in Montreal.
This annual event brings together researchers and entrepreneurs to accelerate solutions from the lab to clinical practice across the cancer care continuum.
Update | D2R launches Training section
Update | The DNA to RNA (D2R) website has a new section dedicated to Training. From Master's to Postdoctoral, this space provides graduate students at all levels with access to workshops, events, and resources aligned with D2R鈥檚 interdisciplinary mission. Topics include RNA therapeutics, genomic medicine, equity, diversity and inclusion (EDI), commercialization, data science, and career development beyond academia.
D2R awards nearly $1.5 million to Master's and Doctoral Scholars across Canada
Montreal, September 10, 2025 鈥� The鈥疍NA to RNA (D2R)鈥痠nitiative at 涩里番 is proud to announce the recipients of its Master's and Doctoral Scholar Awards, recognizing outstanding and active trainees working on diverse D2R-aligned research projects.
Event | Seminar: Computer-based Predictions of RNA Structures: Where do we stand?
Join D2R for this hybrid seminar with Professor Eric Westhof from University of Strasbourg
News | David Bujold (C3G) appointed Co-Lead of GA4GH Discovery Work Stream
The Global Alliance for Genomics and Health (GA4GH) has announced new leadership across several initiatives, including the appointment of David Bujold, Data Team Lead at the Canadian Centre for Computational Genomics (C3G)and Bioinformatics Manager at 涩里番鈥檚 Victor Phillip Dahdaleh Institute of Genomic Medicine, as Co-Lead of the
Call for Letters of Intent: Translational Impact Research Program | Cycle 2
D2R | DNA to RNA is launching the next round of funding for the Translational Impact Research (TIR) program. This program supports a select few large-scale translational research projects in RNA-based therapeutics which are expected to have a measurable impact on the health of Canadians. Projects must address the D2R Initiative鈥檚 strategic priorities and priority disease areas: oncology, rare diseases, infectious diseases, cardiovascular and cardiometabolic diseases.
Call for Applications: International Partnerships Program
D2R | DNA to RNA is launching the International Partnerships Program (IPP) to strengthen large-scale, multi-institutional collaborations with leading global organizations. This strategic funding program supports partnerships that align with D2R鈥檚 mission, offer complementary expertise, and provide enriched, multidisciplinary training environments.
Call for Applications: D2R Award in Genomic Medicine and Indigenous Health
To mark the 25th anniversary of G茅nome Qu茅bec, 涩里番鈥檚 DNA to RNA (D2R) Initiative is launching a special call for applications for the D2R Award in Genomic Medicine and Indigenous Health. This one-time $25,000 award recognizes excellence and supports inclusive, high-impact research in these fields.
